| JPM PACIFIC EQUITY D (ACC) EUR | RVI ASIA PACÍFICO | 23,010000 | 30/09/2026 | 21,11% | 57,82% | * |
| JPM PACIFIC EQUITY D (ACC) USD | RVI ASIA PACÍFICO | 34,636724 | 30/09/2026 | 21,34% | 58,30% | * |
| JPM PACIFIC EQUITY I2 (ACC) EUR | RVI ASIA PACÍFICO | 207,890000 | 30/09/2026 | 22,83% | 66,98% | ** |
| JPM PACIFIC EQUITY I2 (ACC) USD | RVI ASIA PACÍFICO | 144,024659 | 30/09/2026 | 23,06% | 67,19% | ** |
| JPM PACIFIC EQUITY I (ACC) USD | RVI ASIA PACÍFICO | 238,793483 | 30/09/2026 | 22,79% | 66,01% | ** |
| JPM SGD LIQUIDITY LVNAV AGENCY (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,689513 | 30/09/2026 | 4,15% | -0,41% | * |
| JPM SGD LIQUIDITY LVNAV C (ACC) | RFI ASIA PACÍFICO EX-JAPÓN | 8.068,503068 | 30/09/2026 | 4,99% | 6,73% | *** |
| JPM SGD LIQUIDITY LVNAV C (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,689513 | 30/09/2026 | 4,15% | -0,41% | * |
| JPM SGD LIQUIDITY LVNAV CORE (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,689513 | 30/09/2026 | 4,15% | · | ND |
| JPM SGD LIQUIDITY LVNAV E (ACC) | RFI ASIA PACÍFICO EX-JAPÓN | 7.731,255602 | 30/09/2026 | 5,08% | 7,07% | *** |
| JPM SGD LIQUIDITY LVNAV E (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,689513 | 30/09/2026 | 4,15% | -0,41% | * |
| JPM SGD LIQUIDITY LVNAV INSTITUTIONAL (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 0,689513 | 30/09/2026 | 4,15% | -0,41% | * |
| JPM TAIWAN A (ACC) EUR | RVI CHINA | 124,230000 | 30/09/2026 | 86,22% | 200,65% | ***** |
| JPM TAIWAN A (ACC) USD | RVI CHINA | 98,511669 | 30/09/2026 | 86,58% | 200,32% | ***** |
| JPM TAIWAN A (DIST) USD | RVI CHINA | 70,462351 | 30/09/2026 | 86,47% | 195,27% | ***** |
| JPM TAIWAN C (ACC) USD | RVI CHINA | 129,713782 | 30/09/2026 | 87,77% | 208,03% | ***** |
| JPM TAIWAN C (DIST) USD | RVI CHINA | 497,754293 | 30/09/2026 | 86,64% | 197,25% | ***** |
| JPM TAIWAN D (ACC) USD | RVI CHINA | 74,768824 | 30/09/2026 | 85,19% | 191,42% | ***** |
| JPM TAIWAN I (ACC) EUR | RVI CHINA | 611,570000 | 30/09/2026 | 87,46% | 208,76% | ***** |
| JPM TAIWAN I (ACC) USD | RVI CHINA | 518,996037 | 30/09/2026 | 87,81% | 208,43% | ***** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 118,864739 | 30/09/2026 | 15,94% | 30,25% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 123,850000 | 30/09/2026 | 19,80% | 36,16% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | RVI BIOTECNOLOGÍA | 118,740643 | 30/09/2026 | 24,48% | 33,47% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 118,790884 | 30/09/2026 | 15,94% | 30,21% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 123,240000 | 30/09/2026 | 19,77% | 35,92% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | RVI BIOTECNOLOGÍA | 118,132981 | 30/09/2026 | 24,43% | 33,21% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 123,412112 | 30/09/2026 | 16,45% | 32,45% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 128,040000 | 30/09/2026 | 20,29% | 38,24% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 164,059301 | 30/09/2026 | 24,29% | 46,41% | *** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | RVI BIOTECNOLOGÍA | 122,738882 | 30/09/2026 | 24,98% | 35,49% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 121,702891 | 30/09/2026 | 16,06% | 31,13% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 126,280000 | 30/09/2026 | 19,91% | 36,95% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 161,613798 | 30/09/2026 | 23,84% | 44,84% | *** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 121,012770 | 30/09/2026 | 24,59% | 34,17% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 103,950000 | 30/09/2026 | 20,17% | 37,85% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 99,330691 | 30/09/2026 | 24,87% | 35,10% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) GBP | RVI BIOTECNOLOGÍA | 98,194540 | 30/09/2026 | 24,43% | 33,80% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 70,955526 | 30/09/2026 | 24,60% | 33,90% | ** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 97,060000 | 30/09/2026 | 18,92% | 32,11% | ** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 79,348305 | 30/09/2026 | 23,52% | 29,31% | ** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 121,270000 | 30/09/2026 | 20,32% | 38,40% | ** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 89,889916 | 30/09/2026 | 25,01% | 35,64% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 88,000000 | 30/09/2026 | 24,68% | 35,09% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 85,230000 | 30/09/2026 | 20,23% | 38,02% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 154,820000 | 30/09/2026 | 15,65% | 44,31% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 154,724791 | 30/09/2026 | 15,86% | 44,51% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | MIXTO AGRESIVO GLOBAL | 109,020000 | 30/09/2026 | 12,90% | 32,84% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 108,850000 | 30/09/2026 | 10,90% | 21,84% | * |
| JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | MIXTO AGRESIVO GLOBAL | 176,520000 | 30/09/2026 | 16,30% | 47,60% | ***** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | MIXTO AGRESIVO GLOBAL | 142,230000 | 30/09/2026 | 15,08% | 41,52% | **** |